Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Accumulated Expenses (2016 - 2025)

Bio Key International's Accumulated Expenses history spans 16 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Accumulated Expenses fell 3.19% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, down 3.19%, while the annual FY2024 figure was $1.3 million, 290.75% up from the prior year.
  • Accumulated Expenses for Q3 2025 was $1.2 million at Bio Key International, up from $1.2 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.3 million in Q4 2024 and bottomed at $327252.0 in Q4 2023.
  • The 5-year median for Accumulated Expenses is $895453.0 (2022), against an average of $902055.5.
  • The largest annual shift saw Accumulated Expenses plummeted 54.3% in 2022 before it surged 290.75% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $828997.0 in 2021, then tumbled by 54.3% to $378874.0 in 2022, then dropped by 13.63% to $327252.0 in 2023, then soared by 290.75% to $1.3 million in 2024, then fell by 5.03% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Accumulated Expenses are $1.2 million (Q3 2025), $1.2 million (Q2 2025), and $1.0 million (Q1 2025).